Strategic Considerations for Building a High-Value IP Portfolio for New Molecular Entities (Millbrae)

Date:

Wednesday, February 5, 2014

Speaker(s):

Atulya Agarwal and Mark Kresnak, Dickstein Shapiro LLP

Location:

Westin San Francisco Airport
1 Bayshore Highway
Milbrea, CA 94030
United States

RSVP:

510.226.7800 or support@acc-sfba.com

Fee:

members free, nonmembers $50

Time:

11:30 am-1:30 pm

CLE Credits:

1 CA hr

Intellectual property can be a life science company's most valuable asset. Being able to strategically leverage the full value of those assets while navigating complex third-party IP landscapes is essential for success in the biotechnology and pharmaceutical sectors. This session will discuss strategies for building a high-value life sciences IP portfolio, specifically focusing on IP considerations relating to new biological vs. new chemical entities.

Location

Javascript is required to view this map.